China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake

Rhea-AI Filing Summary

China SXT Pharmaceuticals, Inc. director and Co-CEO Zhou Feng Felix filed an initial ownership report showing indirect holdings of the company’s equity. The filing reports 4 Class B Ordinary Shares held through Feng Zhou Management Limited, a British Virgin Islands company 100% owned and controlled by Feng Zhou.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zhou Feng Felix

Role Co-CEO and Director

Type	Security	Shares	Price	Value
holding	Class B Ordinary Shares	--	--	--

Holdings After Transaction: Class B Ordinary Shares — 4 shares (Indirect, See Footnote)

Footnotes (1)

1. [object Object]

Key Figures

Indirect Class B holdings: 4 Class B Ordinary Shares Form type: Form 3 Holding entry count: 1 holding entry

3 metrics

Indirect Class B holdings 4 Class B Ordinary Shares Indirectly held via Feng Zhou Management Limited

Form type Form 3 Initial statement of beneficial ownership

Holding entry count 1 holding entry Non-transactional ownership record

Key Terms

Class B Ordinary Shares, indirect, dispositive control

3 terms

Class B Ordinary Shares financial

"Represents 4 Class B Ordinary Shares held by Feng Zhou Management Limited"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

indirect financial

"total_shares_following_transaction 4.0000, direct_or_indirect I, ownership_type indirect"

dispositive control financial

"Feng Zhou, who has the power and dispositive control over such securities"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhou Feng Felix

(Last) (First) (Middle)

NO.35 GELIAN VILLAGE, LIANGXU TOWN

(Street)

JIANGYAN JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/04/2017

3. Issuer Name and Ticker or Trading Symbol
China SXT Pharmaceuticals, Inc. [ SXTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-CEO and Director

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B Ordinary Shares	4	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 4 Class B Ordinary Shares held by Feng Zhou Management Limited, a British Virgin Islands company that is 100% owned by Feng Zhou, who has the power and dispositive control over such securities.

	/s/ Feng Zhou	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Zhou Feng Felix report owning in China SXT Pharmaceuticals (SXTC)?

Zhou Feng Felix reports indirect ownership of 4 Class B Ordinary Shares of China SXT Pharmaceuticals. These shares are reported on an initial Form 3, which discloses existing beneficial ownership when someone becomes a director, officer, or large shareholder of a public company.

How are the reported China SXT Pharmaceuticals (SXTC) shares held?

The 4 Class B Ordinary Shares are held indirectly through Feng Zhou Management Limited, a British Virgin Islands company. According to the disclosure, this entity is 100% owned by Feng Zhou, who has power and dispositive control over the securities held by the company.

Is the Form 3 for China SXT Pharmaceuticals (SXTC) a buy or sell transaction?

The Form 3 does not report a buy or sell transaction. It records an existing indirect holding of 4 Class B Ordinary Shares as of the reported date, which is standard when an individual becomes an insider and must disclose their current beneficial ownership stake.

What role does Zhou Feng Felix hold at China SXT Pharmaceuticals (SXTC)?

Zhou Feng Felix is identified as a Co-CEO and Director of China SXT Pharmaceuticals. Form 3 is required for such insiders to disclose their beneficial ownership, and this filing shows his indirect interest in 4 Class B Ordinary Shares through a controlled entity.

How much control does Zhou Feng have over the reported SXTC shares?

The footnote states that Feng Zhou Management Limited is 100% owned by Feng Zhou, who has power and dispositive control over the securities. This means he controls decisions regarding the 4 Class B Ordinary Shares reported as indirectly owned in the Form 3.